Narsoplimab (OMS 721) is a selective whole-human immunoglobulin gamma-4 (IgG4) monoclonal antibody and a mannan-binding lectin-associated serine protease-2 (MASP-2) inhibitor that binds MASP-2 to prevent lectin pathway activation and inhibit the agglutinin pathway. It is used to study diseases associated with hematopoietic stem cell transplantation in adults.
Purity:
95.00%
CAS Number:
[2108782-45-0]
Target:
SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted